| Venus Remedies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 526953 |
NSE Symbol : VENUSREM |
P/E(TTM) : 18.76 |
|
ISIN Demat : INE411B01019 |
Div & Yield% : 0.63 |
EPS(TTM) : 84.64 |
|
Book Value(₹) : 515.92 |
Market Cap(₹Cr) : 2,122.41 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 178.80 | 259.01 | 179.95 | 192.65 | 137.13 | 196.74 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 178.80 | 259.01 | 179.95 | 192.65 | 137.13 | 196.74 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.55 | 4.64 | 2.41 | 1.68 | 2.72 | 4.08 |
| Total Income | 181.35 | 263.65 | 182.36 | 194.33 | 139.85 | 200.82 |
| Total Expenditure | 142.24 | 199.57 | 143.23 | 162.81 | 119.20 | 171.49 |
| PBIDT | 39.11 | 64.08 | 39.13 | 31.52 | 20.65 | 29.33 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 39.11 | 64.08 | 39.13 | 31.52 | 20.65 | 29.33 |
| Depreciation | 6.51 | 6.51 | 6.32 | 5.92 | 5.95 | 4.49 |
| Tax | 8.20 | 14.48 | 8.25 | 6.45 | 3.70 | 8.21 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.13 | -0.36 | -0.36 | -0.09 | -0.69 | 1.84 |
| Reported Profit After Tax | 25.53 | 43.45 | 24.92 | 19.24 | 11.69 | 14.79 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 25.53 | 43.45 | 24.92 | 19.24 | 11.69 | 14.79 |
| EPS (Unit Curr.) | 19.10 | 32.51 | 18.64 | 14.40 | 8.75 | 11.07 |
| EPS (Adj) (Unit Curr.) | 19.10 | 32.51 | 18.64 | 14.40 | 8.75 | 11.07 |
| Calculated EPS (Unit Curr.) | 19.09 | 32.50 | 18.64 | 14.39 | 8.74 | 11.06 |
| Calculated EPS (Adj) (Unit Curr.) | 19.09 | 32.50 | 18.64 | 14.39 | 8.74 | 11.06 |
| Calculated EPS (Ann.) (Unit Curr.) | 76.38 | 129.99 | 74.55 | 57.56 | 34.97 | 44.25 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 76.38 | 129.99 | 74.55 | 57.56 | 34.97 | 44.25 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.37 | 13.37 | 13.37 | 13.37 | 13.37 | 13.37 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 21.87 | 24.74 | 21.74 | 16.36 | 15.06 | 14.91 |
| PBDTM(%) | 21.87 | 24.74 | 21.74 | 16.36 | 15.06 | 14.91 |
| PATM(%) | 14.28 | 16.78 | 13.85 | 9.99 | 8.52 | 7.52 |
